Quantitative phosphoproteomic profiling of human non-small cell lung cancer tumors

Journal of Proteomics

Volumn 91, Issue , 2013, Pages 286-296

  Schweppe, Devin K ^a   Rigas, James R ^a   Gerber, Scott A ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Lung cancer; Phosphoproteomics; Quantitative proteomics; SILAC

Indexed keywords

ARGININE; LYSINE; PHOSPHOPEPTIDE;

ARTICLE; CANCER CELL CULTURE; CANCER TISSUE; CELL GROWTH; CELL LABELING; GENOMICS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LUNG NON SMALL CELL CANCER; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEOMICS; QUANTITATIVE ANALYSIS; STANDARD; TUMOR CELL;

LUNG CANCER; PHOSPHOPROTEOMICS; QUANTITATIVE PROTEOMICS; SILAC;

AMINO ACID MOTIFS; ARGININE; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; ISOTOPE LABELING; LUNG NEOPLASMS; LYSINE; MUTATION; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTEOME; PROTEOMICS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION;

EID: 84883001984     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2013.07.023     Document Type: Article

References (54)

1. Siegel R., Ward E., Brawley O., Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011, 61(4):212-236.
2. Herbst R.S., Heymach J.V., Lippman S.M. Lung cancer. N Engl J Med 2008, 359(13):1367-1380.
3. Roberts P.J., Der C.J. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene 2007, 26(22):3291-3310.
4. Bose R., Molina H., Patterson A.S., Bitok J.K., Periaswamy B., Bader J.S., et al. Phosphoproteomic analysis of Her2/neu signaling and inhibition. Proc Natl Acad Sci U S A 2006, 103(26):9773-9778.
5. Hammond D.E., Hyde R., Kratchmarova I., Beynon R.J., Blagoev B., Clague M.J. Quantitative analysis of HGF and EGF-dependent phosphotyrosine signaling networks. J Proteome Res 2010, 9(5):2734-2742.
6. Kettenbach A.N., Schweppe D.K., Faherty B.K., Pechenick D., Pletnev A.A., Gerber S.A. Quantitative phosphoproteomics identifies substrates and functional modules of aurora and polo-like kinase activities in mitotic cells. Sci Signal 2011, 4(179):rs5.
7. Ross P.L., Huang Y.N., Marchese J.N., Williamson B., Parker K., Hattan S., et al. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics 2004, 3(12):1154-1169.
8. Gygi S.P., Rist B., Gerber S.A., Turecek F., Gelb M.H., Aebersold R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol 1999, 17(10):994-999.
9. Gerber S.A., Rush J., Stemman O., Kirschner M.W., Gygi S.P. Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS. Proc Natl Acad Sci U S A 2003, 100(12):6940-6945.
10. Kettenbach A.N., Rush J., Gerber S.A. Absolute quantification of protein and post-translational modification abundance with stable isotope-labeled synthetic peptides. Nat Protoc 2011, 6(2):175-186.
11. Liu H., Sadygov R.G., Yates J.R. A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal Chem 2004, 76(14):4193-4201.
12. Ong S.E., Blagoev B., Kratchmarova I., Kristensen D.B., Steen H., Pandey A., et al. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics 2002, 1(5):376-386.
13. Brewis I.A., Brennan P. Proteomics technologies for the global identification and quantification of proteins. Adv Protein Chem Struct Biol 2011, 80:1-44.
14. Ong S.E., Foster L.J., Mann M. Mass spectrometric-based approaches in quantitative proteomics. Methods 2003, 29(2):124-130.
15. Ishihama Y., Sato T., Tabata T., Miyamoto N., Sagane K., Nagasu T., et al. Quantitative mouse brain proteomics using culture-derived isotope tags as internal standards. Nat Biotechnol 2005, 23(5):617-621.
16. Geiger T., Cox J., Ostasiewicz P., Wisniewski J.R., Mann M. Super-SILAC mix for quantitative proteomics of human tumor tissue. Nat Methods 2010, 7(5):383-385.
17. Monetti M., Nagaraj N., Sharma K., Mann M. Large-scale phosphosite quantification in tissues by a spike-in SILAC method. Nat Methods 2011, 8(8):655-658.
18. Deeb S.J., D'Souza R.C., Cox J., Schmidt-Supprian M., Mann M. Super-SILAC allows classification of diffuse large B-cell lymphoma subtypes by their protein expression profiles. Mol Cell Proteomics 2012, 11(5):77-89.
19. Wisniewski J.R., Dus K., Mann M. Proteomic workflow for analysis of archival formalin fixed and paraffin embedded clinical samples to a depth of 10,000 proteins. Proteomics Clin Appl Apr. 2013, 7(3-4):225-233.
20. Sandberg A., Lindell G., Kallstrom B.N., Branca R.M., Danielsson K.G., Dahlberg M., et al. Tumor proteomics by multivariate analysis on individual pathway data for characterization of vulvar cancer phenotypes. Mol Cell Proteomics 2012, 11(7). [M112 016998].
21. Boersema P.J., Geiger T., Wisniewski J.R., Mann M. Quantification of the N-glycosylated secretome by super-SILAC during breast cancer progression and in human blood samples. Mol Cell Proteomics Jan. 2013, 12(1):158-171.
22. Narumi R., Murakami T., Kuga T., Adachi J., Shiromizu T., Muraoka S., et al. A strategy for large-scale phosphoproteomics and SRM-based validation of human breast cancer tissue samples. J Proteome Res Nov. 2 2012, 11(11):5311-5322.
23. Albanell J., Lonardo F., Rusch V., Engelhardt M., Langenfeld J., Han W., et al. High telomerase activity in primary lung cancers: association with increased cell proliferation rates and advanced pathologic stage. J Natl Cancer Inst 1997, 89(21):1609-1615.
24. Petty W.J., Dragnev K.H., Memoli V.A., Ma Y., Desai N.B., Biddle A., et al. Epidermal growth factor receptor tyrosine kinase inhibition represses cyclin D1 in aerodigestive tract cancers. Clin Cancer Res 2004, 10(22):7547-7554.
25. Kettenbach A.N., Gerber S.A. Rapid and reproducible single-stage phosphopeptide enrichment of complex peptide mixtures: application to general and phosphotyrosine-specific phosphoproteomics experiments. Anal Chem Oct. 15 2011, 83(20):7635-7644.
26. Eng J.K., McCormack A.L., Yates Iii J.R. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J Am Soc Mass Spectrom 1994, 5(11):976-989.
27. Faherty B.K., Gerber S.A. MacroSEQUEST: efficient candidate-centric searching and high-resolution correlation analysis for large-scale proteomics data sets. Anal Chem 2010, 82(16):6821-6829.
28. Elias J.E., Gygi S.P. Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nat Methods 2007, 4(3):207-214.
29. Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P. A probability-based approach for high-throughput protein phosphorylation analysis and site localization. Nat Biotechnol 2006, 24(10):1285-1292.
30. Hsieh E.J., Hoopmann M.R., Maclean B., Maccoss M.J. Comparison of database search strategies for high precursor mass accuracy MS/MS data. J Proteome Res 2010, 9(2):1138-1143.
31. Villen J., Gygi S.P. The SCX/IMAC enrichment approach for global phosphorylation analysis by mass spectrometry. Nat Protoc 2008, 3(10):1630-1638.
32. Han D.K., Eng J., Zhou H., Aebersold R. Quantitative profiling of differentiation-induced microsomal proteins using isotope-coded affinity tags and mass spectrometry. Nat Biotechnol 2001, 19(10):946-951.
33. Geiger T., Wisniewski J.R., Cox J., Zanivan S., Kruger M., Ishihama Y., et al. Use of stable isotope labeling by amino acids in cell culture as a spike-in standard in quantitative proteomics. Nat Protoc 2011, 6(2):147-157.
34. Schwartz D., Gygi S.P. An iterative statistical approach to the identification of protein phosphorylation motifs from large-scale data sets. Nat Biotechnol 2005, 23(11):1391-1398.
35. Larkin M.A., Blackshields G., Brown N.P., Chenna R., McGettigan P.A., McWilliam H., et al. Clustal W and Clustal X version 2.0. Bioinformatics 2007, 23(21):2947-2948.
36. Kosako H., Nagano K. Quantitative phosphoproteomics strategies for understanding protein kinase-mediated signal transduction pathways. Expert Rev Proteomics 2011, 8(1):81-94.
37. Takahashi T., Carbone D., Nau M.M., Hida T., Linnoila I., Ueda R., et al. Wild-type but not mutant p53 suppresses the growth of human lung cancer cells bearing multiple genetic lesions. Cancer Res 1992, 52(8):2340-2343.
38. Forbes S.A., Bindal N., Bamford S., Cole C., Kok C.Y., Beare D., Jia M., Shepherd R., Leung K., Menzies A., Teague J.W., Campbell P.J., Stratton M.R., Futreal P.A. COSMIC: mining complete cancer genomes in the catalogue of somatic mutations in cancer. Nucleic Acids Res 2011, 39(Database issue):D945-D950.
39. Zundelevich A., Elad-Sfadia G., Haklai R., Kloog Y. Suppression of lung cancer tumor growth in a nude mouse model by the Ras inhibitor salirasib (farnesylthiosalicylic acid). Mol Cancer Ther 2007, 6(6):1765-1773.
40. Sordella R., Bell D.W., Haber D.A., Settleman J. Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways. Science 2004, 305(5687):1163-1167.
41. Bendall S.C., Hughes C., Stewart M.H., Doble B., Bhatia M., Lajoie G.A. Prevention of amino acid conversion in SILAC experiments with embryonic stem cells. Mol Cell Proteomics 2008, 7(9):1587-1597.
42. Schmidt F., Strozynski M., Salus S.S., Nilsen H., Thiede B. Rapid determination of amino acid incorporation by stable isotope labeling with amino acids in cell culture (SILAC). Rapid Commun Mass Spectrom 2007, 21(23):3919-3926.
43. Hornbeck P.V., Chabra I., Kornhauser J.M., Skrzypek E., Zhang B. PhosphoSite: a bioinformatics resource dedicated to physiological protein phosphorylation. Proteomics 2004, 4(6):1551-1561.
44. Reorganizing the protein space at the Universal Protein Resource (UniProt). Nucleic Acids Res Jan. 2012, 40(Database issue):D71-D75.
45. Dinkel H., Chica C., Via A., Gould C.M., Jensen L.J., Gibson T.J., et al. Phospho.ELM: a database of phosphorylation sites - update. Nucleic Acids Res 2011, 39(Database issue):D261-D267.
46. Basile V., Mantovani R., Imbriano C. DNA damage promotes histone deacetylase 4 nuclear localization and repression of G2/M promoters, via p53 C-terminal lysines. J Biol Chem 2006, 281(4):2347-2357.
47. Stewart G.S., Wang B., Bignell C.R., Taylor A.M., Elledge S.J. MDC1 is a mediator of the mammalian DNA damage checkpoint. Nature 2003, 421(6926):961-966.
48. Foster E.R., Downs J.A. Histone H2A phosphorylation in DNA double-strand break repair. FEBS J 2005, 272(13):3231-3240.
49. Wolf G., Elez R., Doermer A., Holtrich U., Ackermann H., Stutte H.J., et al. Prognostic significance of polo-like kinase (PLK) expression in non-small cell lung cancer. Oncogene 1997, 14(5):543-549.
50. Strebhardt K., Ullrich A. Targeting polo-like kinase 1 for cancer therapy. Nat Rev Cancer 2006, 6(4):321-330.
51. Raab M., Kappel S., Kramer A., Sanhaji M., Matthess Y., Kurunci-Csacsko E., et al. Toxicity modelling of Plk1-targeted therapies in genetically engineered mice and cultured primary mammalian cells. Nat Commun 2011, 2:395.
52. Abrams S.L., Steelman L.S., Shelton J.G., Wong E.W., Chappell W.H., Basecke J., et al. The Raf/MEK/ERK pathway can govern drug resistance, apoptosis and sensitivity to targeted therapy. Cell Cycle 2010, 9(9):1781-1791.
53. McCubrey J.A., Steelman L.S., Chappell W.H., Abrams S.L., Wong E.W., Chang F., et al. Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. Biochim Biophys Acta 2007, 1773(8):1263-1284.
54. Shaul Y.D., Seger R. The MEK/ERK cascade: from signaling specificity to diverse functions. Biochim Biophys Acta 2007, 1773(8):1213-1226.